Hyperfine, Inc. (NASDAQ:HYPR – Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 2,380,000 shares, an increase of 33.7% from the March 15th total of 1,780,000 shares. Currently, 4.1% of the company’s stock are sold short. Based on an average trading volume of 1,130,000 shares, the days-to-cover ratio is presently 2.1 days.
Wall Street Analyst Weigh In
Several analysts recently weighed in on the company. Lake Street Capital began coverage on Hyperfine in a report on Monday, March 24th. They issued a “buy” rating and a $1.50 price objective for the company. Wells Fargo & Company increased their price objective on Hyperfine from $1.10 to $1.29 and gave the stock an “equal weight” rating in a report on Tuesday, March 18th. Finally, B. Riley decreased their price target on Hyperfine from $1.50 to $1.20 and set a “buy” rating for the company in a research note on Thursday, March 20th.
Check Out Our Latest Stock Report on Hyperfine
Institutional Investors Weigh In On Hyperfine
Hyperfine Trading Up 4.1 %
HYPR stock traded up $0.03 during trading on Friday, hitting $0.70. 111,834 shares of the stock traded hands, compared to its average volume of 383,238. The stock has a market cap of $54.18 million, a price-to-earnings ratio of -1.22 and a beta of 1.05. Hyperfine has a one year low of $0.58 and a one year high of $1.90. The company has a 50 day simple moving average of $0.87 and a 200 day simple moving average of $0.96.
Hyperfine (NASDAQ:HYPR – Get Free Report) last announced its earnings results on Monday, March 17th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.02. The company had revenue of $2.32 million for the quarter, compared to analyst estimates of $2.30 million. Hyperfine had a negative net margin of 309.42% and a negative return on equity of 57.54%. During the same period in the prior year, the business earned ($0.15) earnings per share. As a group, analysts predict that Hyperfine will post -0.57 earnings per share for the current fiscal year.
About Hyperfine
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Featured Articles
- Five stocks we like better than Hyperfine
- What is a Low P/E Ratio and What Does it Tell Investors?
- With a 60%+ Upside, There’s Plenty to Love About Lovesac
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- There Are Different Types of Stock To Invest In
- AppLovin: Can Record Profits Overcome Market Skepticism?
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.